Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2021 | 2 |
2022 | 3 |
2023 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Therapeutic Potential for Targeting Autophagy in ER+ Breast Cancer.
Cancers (Basel). 2022 Sep 1;14(17):4289. doi: 10.3390/cancers14174289.
Cancers (Basel). 2022.
PMID: 36077830
Free PMC article.
Review.
Modulating donor mitochondrial fusion/fission delivers immunoprotective effects in cardiac transplantation.
Tran DT, Tu Z, Alawieh A, Mulligan J, Esckilsen S, Quinn K, Sundararaj K, Wallace C, Finnegan R, Allen P, Mehrotra S, Atkinson C, Nadig SN.
Tran DT, et al. Among authors: finnegan r.
Am J Transplant. 2022 Feb;22(2):386-401. doi: 10.1111/ajt.16882. Epub 2021 Nov 8.
Am J Transplant. 2022.
PMID: 34714588
Free PMC article.
Item in Clipboard
Emphysema-associated Autoreactive Antibodies Exacerbate Post-Lung Transplant Ischemia-Reperfusion Injury.
Patel KJ, Cheng Q, Stephenson S, Allen DP, Li C, Kilkenny J, Finnegan R, Montalvo-Calero V, Esckilsen S, Vasu C, Goddard M, Nadig SN, Atkinson C.
Patel KJ, et al. Among authors: finnegan r.
Am J Respir Cell Mol Biol. 2019 Jun;60(6):678-686. doi: 10.1165/rcmb.2018-0224OC.
Am J Respir Cell Mol Biol. 2019.
PMID: 30571141
Free PMC article.
Item in Clipboard
Autophagy-Dependent Sensitization of Triple-Negative Breast Cancer Models to Topoisomerase II Poisons by Inhibition of the Nucleosome Remodeling Factor.
Tyutyunyk-Massey L, Sun Y, Dao N, Ngo H, Dammalapati M, Vaidyanathan A, Singh M, Haqqani S, Haueis J, Finnegan R, Deng X, Kirberger SE, Bos PD, Bandyopadhyay D, Pomerantz WCK, Pommier Y, Gewirtz DA, Landry JW.
Tyutyunyk-Massey L, et al. Among authors: finnegan r.
Mol Cancer Res. 2021 Aug;19(8):1338-1349. doi: 10.1158/1541-7786.MCR-20-0743. Epub 2021 Apr 2.
Mol Cancer Res. 2021.
PMID: 33811160
Free PMC article.
Item in Clipboard
The BET inhibitor/degrader ARV-825 prolongs the growth arrest response to Fulvestrant + Palbociclib and suppresses proliferative recovery in ER-positive breast cancer.
Finnegan RM, Elshazly AM, Patel NH, Tyutyunyk-Massey L, Tran TH, Kumarasamy V, Knudsen ES, Gewirtz DA.
Finnegan RM, et al.
Front Oncol. 2023 Jan 18;12:966441. doi: 10.3389/fonc.2022.966441. eCollection 2022.
Front Oncol. 2023.
PMID: 36741704
Free PMC article.
Item in Clipboard
Cite
Cite